Polymorphisms of tumor-necrosis factor-α-308 and lymphotoxin-α + 250: Possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells

Leukemia and Lymphoma

Volumn 49, Issue 11, 2008, Pages 2163-2169

  Jevtovic Stoimenov, Tatjana ^a   Kocic, Gordana ^a   Pavlovic, Dusica ^a   MaČukanovic Golubović, Lana ^b   Marjanovic, Goran ^b   Djordjevic, Vidosava ^a   Toŝic, Nataŝa ^c   Pavlović, Sonja ^c  

^a UNIVERSITY OF NI   (Serbia)

^b Clinical Centre of Ni   (Serbia)

^c Institute for Molecular Genetics and Genetic Engineering   (Serbia)

Author keywords

Alkaline DNase; Chronic lymphocytic leukemia; LT ; Non Hodgkin lymphoma; TNF

Indexed keywords

DEOXYRIBONUCLEASE; GENOMIC DNA; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MUTATIONAL ANALYSIS; NONHODGKIN LYMPHOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTROPHOTOMETRY; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; APOPTOSIS; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES; DNA FRAGMENTATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LEUKOCYTES, MONONUCLEAR; LYMPHOMA, NON-HODGKIN; LYMPHOTOXIN-ALPHA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57049112004     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802381220     Document Type: Article

References (33)

1. Salles, G., Bienvenu, J., Bastion, Y., Barbier, Y., Doche, C. Warzocha, K. et al. (1996) Elevated circulating levels of TNFα and its p55soluble receptor are associated with an adverse prognosis inlymphoma patients. Br J Haematol, 93, pp. 352-359.
2. Waage, A., Liabakk, N., Lien, E., Lamvik, J. and Espevik, T. (1992) p55 and p75 Tumor necrosis factor receptors in patients with chronic lymphocytic leukemia. Blood, 80, pp. 2577-2583.
3. Warzocha, K., Salles, G., Bienvenu, J., Bastion, Y., Dumontet, C. Renard, N. et al. (1997) Tumour necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients. J Clin Oncol, 15, pp. 499-508.
4. Kung, A. L., Zetterberg, A., Sherwood, S. W. and Schimke, R. T. (1990) Cytotoxic effects of cell cycle phase specific agents: Result of cell cycle perturbation. Cancer Res, 50, pp. 7307-7317.
5. Arends, M. J., Morris, R. G. and Wyllie, A. H. (1990) Apoptosis: The role of the endonuclease. Am J Pathol, 136, pp. 593-608.
6. Browning, J. L., Ngam-ek, A., Lawton, P., DeMarinis, J., Tizard, R. Chow, E. P. et al. (1993) Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell, 72, pp. 847-856.
7. Hajeer, A. H. and Hutchinson, I. V. (2000) TNF-α gene polymorphism: Clinical and biological implications. Microsc Res Techn, 50, pp. 216-228.
8. Messer, G., Spengler, U., Jung, M. C., Honold, G., Blomer, K. Pape, G. R. et al. (1991) Polymorphic structure of the tumor necrosis factor (TNF) locus: An NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production. J Exp Med, 173, p. 209.
9. Pociot, F., Briant, L., Jongeneel, C. V., Mölvig, J., Worsaae, H. Abbal, M. et al. (1993) Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: A possible link to insulin-dependent diabetes mellitus. Eur J Immunol, 23, pp. 224-231.
10. Bouma, G., Crusius, J. B., Oudkerk Pool, M, Kolkman, J. J. von Blomberg, B. M. et al. (1996) Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphism in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol, 43, pp. 456-463.
11. Fisher, D. E. (1994) Apoptosis in cancer therapy: Crossing the threshold. Cell, 78, p. 539.
12. Waterer, G. W., Quasney, M. W., Cantor, R. M. and Wunderink, R. G. (2001) Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med, 163, pp. 1599-1604.
13. Bøyum, A. (1983) Isolation of human blood monocytes with nycodenz - a new non-ionic iodinated gradient medium. J Immunol, 17, pp. 429-436.
14. Bartholeyns, J., Peeters-Joris, C., Reychler, H. and Baudhun, P. (1975) Hepatic nucleases 1. Method for the specific determination and characterization in rat liver. Eur J Biochem, 57, pp. 205-211.
15. van Kooten, C., Rensink, I., Aarden, L. and van Oers, R. (1993) Cytokines and intracellular signals involved in the regulation of B-CLL proliferation. Leuk Lymphoma, 12, pp. 27-33.
16. Boussiotis, V. A., Nadler, L. M., Strominger, J. L. and Goldfeld, A. E. (1994) Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. Proc Natl Acad Sci USA, 91, pp. 7007-7011.
17. Hoffbrand, A. V., Panayiotidis, P., Reittie, J. and Ganeshaguru, K. (1993) Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin Hematol, 30, pp. 306-317.
18. Foa, R., Massaia, M., Cardona, S., Tos, A. G., Bianchi, A. Attisano, C. et al. (1990) Production of tumor necrosis factor-alpha by B-cell chronic lymphocytic leukemia cells: A possible regulatory role of TNF in the progression of the disease. Blood, 76, pp. 393-400.
19. Gibbons, P. L., Rowe, M., Cope, A. P., Feldmann, M. and Brennan, F. M. (1994) Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differential Burkitt lymphoma cell lines. Eur J Immunol, 24, pp. 1879-1893.
20. Gruss, H. J. and Dower, S. K. (1995) TNF Ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood, 85, pp. 3378-3404.
21. Wihlborg, C., Sjoberg, J., Intaglietta, M., Axdorph, U., Pisa, E. J. and Pisa, P. (1999) Tumour necrosis factor-α cytokine promoter gene polymorphism in Hodgkin's disease and chronic lymphocytic leukemia. Br J Haematol, 104, pp. 346-349.
22. Mainou-Fowler, T., Dickinson, A. M., Taylor, P RA, Mounter, P., Jack, F. Proctor, S. J. et al. (2000) Tumor necrosis factor gene polymorphisms in lymphoproliferative disease. Leuk Lymphoma, 38, pp. 547-552.
23. Demeter, J., Porzsolt, F., Ramisch, S., Schmidt, D., Schmidt, M. and Messer, G. (1997) Polymorphism of the tumor necrosis factor-alpha and lymphotoxin-alpha genes in chronic lymphocytic leukemia. Br J Haematol, 97, pp. 107-112.
24. Seidemann, K., Zimmermann, M., Book, M., Meyer, U., Burkhardt, B. Welte, K. et al. (2005) Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: Resultsfrom Berlin-Frankfurt-Munster trial NHL-BFM 95. J Clin Oncol, 23, pp. 8414-8421.
25. Sullivan, K. E., Wooten, C., Schmeckpeper, D., Goldman, D. and Petri, M. (1997) A promoter polymorphism of tumor necrosis alpha is associated with systemic lupus erythematosus in African Americans. Arthritis Rheum, 40, pp. 2207-2211.
26. Cebrera, M., Shaw, M. A., Sharples, C., Williams, H., Castes, M., Convit, J. and Blackwell, J. M. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med, 182, pp. 1259-1264.
27. McGuire, W., Hill, A. V., Allsoo, C. E., Greenwood, B. M. and Kwiatkowski, D. (1994) Variation in the TNF-alpha promoter region asociated with susceptibility to cerebral malaria. Nature, 371, pp. 508-510.
28. Mira, J. P., Cariou, A., Grall, F., Delclaux, C., Losser, M. R. Heshmati, F. et al. (1999) Association of TNF2 - a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: A multycenter study. JAMA, 282, pp. 561-568.
29. Kazzi, S. N., Jacques, S. M., Qureshi, F., Quasney, M. W., Kim, U. O. and Buhimschi, I. A. (2004) Tumor necrosis factor-alpha allele lymphotoxin-alpha + 250 is associated with the presence and severity of placental inflammation among preterm births. Pediatr Res, 56, pp. 94-98.
30. Warzocha, K., Ribeiro, P. Bienvenu, J, Roy P, Charlot C, Rigal D et al. (1998) Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood, 91, pp. 3574-3581.
31. Messmer, B. T., Messmer, D., Allen, S. L., Kolitz, J. E., Kudalkar, P. Cesar, D. et al. (2005) In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest, 115, pp. 755-764.
32. Fahey, J. L. and Bogs, D. R. (1960) Serum protein changes in malignant disease I. The acute leukemias. Blood, 16, p. 1479.
33. Gavasto, F., Marinc, C. and Pileri, A. (1960) Proliferative capacity of acute leukemia cells. Nature, 187, p. 611.